This review covers tirzepatide for weight reduction in people without diabetes. The evidence for the dual agonist's anti-obesity indication is synthesized for clinical practice guidance.
Abstract
Jastreboff AM, Aronne LJ, Ahmad NN,Tirzepatide Once Weekly for the Treatment of Obesity.2022;387:205-216.
Keywords
Drug-Related Side Effects and Adverse ReactionsTherapeutics